SCHEMBL18289486

SCHEMBL18289486

CCOCCOCCOCCOCCOCCOP(=S)(OCCCCCNC(=O)CCCC1SCC2C1NC(=O)N2C(c1ccccc1)(c1ccc(OC)cc1)c1ccc(OC)cc1)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 3/20 0.38
PRSS2 P07478 3/20 0.38
PRSS3 P35030 3/20 0.38
TPSAB1 Q15661 3/20 0.38
F2 P00734 2/20 0.38
HSP90AB1 P08238 1/20 0.36
PKM P14618 2/20 0.34
GBA1 P04062 1/20 0.34
KEAP1 Q14145 1/20 0.34
PLCD1 P51178 1/20 0.33
SORT1 Q99523 1/20 0.33
GIGYF2 Q6Y7W6 1/20 0.33
SENP1 Q9P0U3 1/20 0.33
FOLH1 Q04609 5/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PLG P00747 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10309833 0.96 PRSS1 (0.36) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL17014130 0.94 PRSS1 (0.38) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL10309866 0.93 PRSS1 (0.36) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL10309850 0.93 F2 (0.36) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL10309861 0.91 PRSS1 (0.38) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL10309843 0.91 PRSS1 (0.38) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL25967790 0.90 PRSS1 (0.36) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL10309818 0.90 PRSS1 (0.36) PRSS1PRSS2PRSS3TPSAB1F2
SCHEMBL9971307 0.83 KEAP1 (0.40) HSP90AB1KEAP1GIGYF2SENP1SMN1; SMN2
SCHEMBL30929050 0.82 HSP90AB1 (0.43) PRSS1PRSS2PRSS3TPSAB1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230285574-A1 CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS FISH & RICHARDSON PC 2023-09-14 US disclosed
US-11723981-B2 Conjugates of tumor necrosis factor inhibitors to functionalized polymers QUIAPEG PHARMACEUTICALS AB (SE) 2023-08-15 US disclosed
US-20160354477-A1 CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS FISH & RICHARDSON PC 2016-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230285574-A1 CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS CD44, EPCAM, ALG1 PRSS1 3076/4885PRSS2 3014/4885PRSS3 2218/4885
US-11723981-B2 Conjugates of tumor necrosis factor inhibitors to functionalized polymers TNF, TNFRSF1A, TNFSF11 PRSS1 2716/4885PRSS2 2651/4885PRSS3 2134/4885
US-20160354477-A1 CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS TNF, TNFRSF1A, TNFSF11 PRSS1 2716/4885PRSS2 2651/4885PRSS3 2134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.